Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-25-023309
Filing Date
2025-11-14
Accepted
2025-11-14 14:20:50
Documents
1
Period of Report
2025-11-06

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1536
  Complete submission text file 0001493152-25-023309.txt   3110
Mailing Address 34 SHREWSBURY AVE SUITE 1C RED BANK NJ 07701
Business Address 1200 ROUTE 22 EAST BRIDGEWATER NJ 08807 302-743-2995
Tharimmune, Inc. (Issuer) CIK: 0001861657 (see all company filings)

EIN.: 842642541 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 20829 W SUMMIT DR KILDEER IL 60047
Business Address
Wendland Mark Paul (Reporting) CIK: 0002096174 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41210 | Film No.: 251484521